APLF anticorps (AA 200-380)

N° du produit ABIN7265649

Détail du produit anti-APLF anticorps

Antigène: APLF (Aprataxin and PNKP Like Factor (APLF))

Épitope: AA 200-380

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp APLF est non-conjugé

Application: Western Blotting (WB)

Fonction: APLF Rabbit pAb

Séquence: LSVPAISGGN VIQGSGKEEI CKDKSQLNTT QQGRRQLISS GSSENTSAEQ DTGEECKNTD QEESTISSKE MPQSFSAITL SNTEMNNIKT NAQRNKLPIE ELGKVSKHKI ATKRTPHKED EAMSCSENCS SAQGDSLQDE SQGSHSESSS NPSNPETLHA KATDSVLQGS EGNKVKRTSC M

Réactivité croisée: Rat

Attributs du produit: Polyclonal Antibodies

Purification: Affinity purification

Immunogène: Recombinant fusion protein containing a sequence corresponding to amino acids 200-380 of human APLF (NP_775816.1).

Isotype: IgG

Information d'application

Indications d'application: WB,1:500 - 1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur APLF

Antigène: APLF (Aprataxin and PNKP Like Factor (APLF))

Autre désignation: APLF (APLF Produits)

Synonymes: anticorps apfl, anticorps palf, anticorps xip1, anticorps APLF, anticorps C2orf13, anticorps DKFZp459J1223, anticorps APFL, anticorps PALF, anticorps Xip1, anticorps 2010301N04Rik, anticorps AI452191, anticorps RGD1565557, anticorps aprataxin and PNKP like factor, anticorps APLF, anticorps aplf, anticorps Aplf

Sujet: C2ORF13 is a component of the cellular response to chromosomal DNA single- and double-strand breaks (Iles et al., 2007 [PubMed 17353262]).[supplied by OMIM, Mar 2008],APFL,C2orf13,PALF,Xip1,ZCCHH1,APLF,Epigenetics & Nuclear Signaling,DNA Damage & Repair,APLF

Poids moléculaire: 56kDa

ID gène: 200558

UniProt: Q8IW19

Pathways: Réparation de l'ADN